{"id":89,"date":"2009-10-23T15:09:45","date_gmt":"2009-10-23T19:09:45","guid":{"rendered":"https:\/\/www.bu.edu\/amyloid\/researchers\/publications\/_2001\/"},"modified":"2012-03-02T12:34:23","modified_gmt":"2012-03-02T17:34:23","slug":"_2001","status":"publish","type":"page","link":"https:\/\/www.bu.edu\/amyloid\/research\/publications\/archive\/_2001\/","title":{"rendered":"2001"},"content":{"rendered":"<p><strong>Akpek G, Lenz G, Lee SM, Sanchorawala V, Wright DG, Colarusso T, Waraska K, Lerner A, Vosburgh E, Skinner M, Comenzo RL<\/strong>:<br \/>\nImmunologic recovery after autologous blood stem cell transpantation in patients with AL-amyloidosis. Bone Marrow Transplantation, 28: 1105-1109, 2001.<\/p>\n<p><strong>Choufani EB, Sanchorawala V, Skinner M, Wright DG, Seldin DC:<\/strong><br \/>\nAcquired factor X deficiency in patients with AL amyloidosis:\u00a0 incidence, bleeding manifestations, and response to high dose chemotherapy.\u00a0 Blood, 97: 1885-1887, 2001.<\/p>\n<p><strong>Chung CM, Connors LH, Benson MB and Walsh MT:<\/strong><br \/>\nBiophysical analysis of normal transthyretin: implications for fibril formation in senile systemic amyloidosis.\u00a0 Amyloid: Journal of Protein Folding Disorders, 8: 75-83, 2001.<\/p>\n<p><strong>Connors LH, Lim A, Prokaeva T, Metayer M, Costello CE, Skinner M<\/strong>:<br \/>\nFamilial transthyretin amyloidosis: recent Boston experience. In: Amyloid and Amyloidosis, Ed by M Bely and A Apathy.\u00a0 Budapest, pp 506-508, 2001.<\/p>\n<p><strong>Costello CE , Lim A, O\u2019Connor PB, Prokaeva T, Connors LH, Skinner M<\/strong>:<br \/>\nIdentification of novel transthyretin variants in familial transthyretin amyloidosis by mass spectrometric peptide mapping. In: Amyloid and Amyloidosis, Ed by M Bely and A Apathy.\u00a0 Budapest, pp.331-333, 2001.<\/p>\n<p><strong>Dember LM, Sanchorawala V, Comenzo RL, Seldin DC, Wright DG, LaValley M, Berk JL, Falk RH, Skinner M<\/strong>:<br \/>\nEffect of intravenous melphalan and autologous blood stem cell transplant on AL amyloidosis-associated renal disease.\u00a0 Annals of Int Med, 134: 746-753, 2001.<\/p>\n<p><strong>Ellis JM, Prokaeva T, Mulligan N, O\u2019Hara CJ, Connors LH, Skinner M, Seldin DC<\/strong>:<br \/>\nVL gene usage in primary amyloidosis. In: Amyloid and Amyloidosis, Ed by M Bely and A Apathy.\u00a0 Budapest, pp. 180-182, 2001.<\/p>\n<p><strong>Gorson KC, Hedley-White ET, Skinner M<\/strong>:<br \/>\nA 64-year old woman with peripheral neuropathy, paraproteinemia, and lymphadenopathy.\u00a0 New Eng J Med, 344: 917-923, 2001.<\/p>\n<p><strong>Liao R, Teller P, Jain M, Connors LH, Skinner M, Falk, RH, Apstein CS<\/strong>:<br \/>\nAcute infusion of Bence Jones protein from patients with amyloidosis causes diastolic dysfunction in isolated mouse hearts.\u00a0 Circulation, 104:\u00a0 1594-1597, 2001.<\/p>\n<p><strong>Libbey CA, Connors LH, Swan N, Skinner M<\/strong>:<br \/>\nAbdominal fat tissue aspirate for diagnosis of amyloidosis- 10 year experience. In: Amyloid and Amyloidosis, Ed by M Bely and A Apathy.\u00a0 Budapest, pp\u00a0 497-499, 2001.<\/p>\n<p><strong>Lim A, Wally J, Walsh MT, Skinner M, Costello CE<\/strong>:<br \/>\nDetection and characterization of post-translational modifications in amyloidogenic kappa 1 light chain proteins by mass spectrometric peptide mapping. In: Amyloid and Amyloidosis, Ed by M Bely and A Apathy.\u00a0 Budapest, pp 199-201, 2001.<\/p>\n<p><strong><a href=\"https:\/\/www.bu.edu\/amyloid\/files\/pdf\/lim-2001.pdf\" target=\"_blank\">Lim A, Wally J, Walsh MT, Skinner M, Costello (PDF)<\/a><\/strong>:<br \/>\nIdentification and localization of a cysteinyl post-translational modification in an amyloidogenic kappa 1 light chain protein by electrospray ionization and matrix-assisted laser desorption\/ionization mass spectrometry.\u00a0 Anal Biochem., 295: 45-56, 2001.<\/p>\n<p><strong>Ng B, Davidoff R, Skinner M, and Falk RH<\/strong>:<br \/>\nParadoxical Clinical and Echocardiographic Findings in Senile versus AL Amyloidosis. In: Amyloid and Amyloidosis, Ed by M Bely and A Apathy.\u00a0 Budapest, pp 392-394, 2001.<\/p>\n<p><strong>Sanchorawala V, Wright DG, Seldin DC, Dember LM, Finn K, Falk RH, Berk J, Quillen K, Skinner M<\/strong>:<br \/>\nStatus report: high-dose chemotherapy with autologous stem cell transplantation for the treatment of AL amyloidosis.\u00a0 Bone Marrow Transplantation, 28:\u00a0 637-642, 2001.<\/p>\n<p><strong>Sanchorawala V, Wright DG, Seldin DC, Muir L, Falk RH, Finn K, Skinner M<\/strong>:<br \/>\nLow Dose Continuous Oral Melphalan for the Treatment of AL Amyloidosis.\u00a0 In: Amyloid and Amyloidosis, Ed by M Bely and A Apathy.\u00a0 Budapest, pp 190-192, 2001.<\/p>\n<p><strong>Shaz BH, Lewis WD, Skinner M, Khettry U<\/strong>:<br \/>\nLivers from patients with apolipoprotein A1 amyloidosis are not suitable as \u201cdomino\u201d donors.\u00a0 Mod Pathol, 14: 577-580, 2001.<\/p>\n<p><strong>Skinner M, Sanchorawala V, Falk RF, Dember LM, Seldin DC, Berk J, Finn K, Libbey CA, Quillen K, LaValley M, and Wright DG<\/strong>:<br \/>\nAL Amyloidosis: Severity of Illness, Treatment Decisions and Outcome in 554 Patients.\u00a0 In: Amyloid and Amyloidosis, Ed by M Bely and A Apathy.\u00a0 Budapest, pp 221-223, 2001.<\/p>\n<p><strong>Swan N, Mulcahy E, Magnani BJ, Skinner M, and O\u2019Hara CJ<\/strong>:<br \/>\nBone Marrow Biopsy Findings in AL Amyloidosis Following Treatment With High-Dose Melphalan and Autologous Stem Cell Support; Correlation with Immunofixation Electrophoresis.\u00a0 In: Amyloid and Amyloidosis, Ed by M Bely and A Apathy.\u00a0 Budapest, pp 253-255, 2001.<\/p>\n<p><strong>Wright DG, Sanchorawala V, Taper J, Seldin DC, Falk RH, Dember LM, Berk J, Finn K, Quillen K, and Skinner M<\/strong>:<br \/>\nHigh Dose Intravenous Melphalan and Autologous Stem Cell Transplantation for the Treatment of AL Amyloidosis: Morbidity and Mortality.\u00a0 In: Amyloid and Amyloidosis, Ed by M Bely and A Apathy.\u00a0 Budapest, pp 193-195, 2001.<\/p>\n<p><strong>Yazaki M, Liepnieks J, Yamashita T, Guenther B, Skinner M, Benson MD<\/strong>:<br \/>\nRenal amyloidosis caused by a novel stop-codon mutation in the apolipoprotein A2 gene.\u00a0 Kidney International, 60: 1658-1665, 2001.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Akpek G, Lenz G, Lee SM, Sanchorawala V, Wright DG, Colarusso T, Waraska K, Lerner A, Vosburgh E, Skinner M, Comenzo RL: Immunologic recovery after autologous blood stem cell transpantation in patients with AL-amyloidosis. Bone Marrow Transplantation, 28: 1105-1109, 2001. Choufani EB, Sanchorawala V, Skinner M, Wright DG, Seldin DC: Acquired factor X deficiency in [&hellip;]<\/p>\n","protected":false},"author":1952,"featured_media":0,"parent":662,"menu_order":13,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/www.bu.edu\/amyloid\/wp-json\/wp\/v2\/pages\/89"}],"collection":[{"href":"https:\/\/www.bu.edu\/amyloid\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.bu.edu\/amyloid\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/amyloid\/wp-json\/wp\/v2\/users\/1952"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/amyloid\/wp-json\/wp\/v2\/comments?post=89"}],"version-history":[{"count":3,"href":"https:\/\/www.bu.edu\/amyloid\/wp-json\/wp\/v2\/pages\/89\/revisions"}],"predecessor-version":[{"id":1640,"href":"https:\/\/www.bu.edu\/amyloid\/wp-json\/wp\/v2\/pages\/89\/revisions\/1640"}],"up":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/amyloid\/wp-json\/wp\/v2\/pages\/662"}],"wp:attachment":[{"href":"https:\/\/www.bu.edu\/amyloid\/wp-json\/wp\/v2\/media?parent=89"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}